Indications and uses
For handwashing when water is not available to decrease bacteria on the skin after changing diapers. after assisting ill persons. before contact with a person under medical care or treatment. recommended for repeated use.
For handwashing when water is not available to decrease bacteria on the skin after changing diapers. after assisting ill persons. before contact with a person under medical care or treatment. recommended for repeated use.
Place a palmful of product in one hand. Spread on both hands and rub into skin until dry (approx. 1-2 min.). Place a smaller amount into one hand. Spread over hands to wrist and rub into skin until dry
Store at room temperature: 15° - 30° C (59° - 86° F).
Ethyl Alcohol, 70% v/v
Antiseptic
For handwashing when water is not available to decrease bacteria on the skin
If swallowed, get medical help or contact a Poison Control Center right away.
TRIAD®
Cat. No. 10-8672 NDC 50730-8672-0
Antiseptic
Hand Gel
72 Packets
Net. Wt. 5 grams each
Triad Group, Inc.
700 West North Shore Drive
Hartland, WI 53029
MADE IN USA
www.triad-group.net
1-800-288-1288
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50730-8672-0 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c351-621f-e053-dbdaa90a74ad | DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50730-8672-0 | ethyl alcohol | 72 in 1 BOX | GEL | 72 | 1 | |
| 50730-8672-0 | ethyl alcohol | 5 g in 1 PACKET | GEL | 5 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50730-8672 | ETHYL ALCOHOL GEL [H AND P INDUSTRIES, INC. DBA TRIAD GROUP] | 1 | Legacy NDC, 2 package rows | 20091121_c2ef3aef-4387-41a0-bdd1-d579dfe4199d.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| alcohol | ACTIVE INGREDIENT | 3K9958V90M | 1 | |
| alcohol | ACTIVE MOIETY | 3K9958V90M | 1 | |
| aloe vera leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| carbomer homopolymer type c | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| denatonium benzoate | INACTIVE INGREDIENT | 4YK5Z54AT2 | 1 | |
| polyethylene glycol 1450 | INACTIVE INGREDIENT | OJ4Z5Z32L4 | 1 | |
| tert-butyl alcohol | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| trolamine | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50730-8672 | 50730-8672-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| alcohol | 3K9958V90M | ACTIB |
| aloe vera leaf | ZY81Z83H0X | IACT |
| carbomer homopolymer type c | 4Q93RCW27E | IACT |
| denatonium benzoate | 4YK5Z54AT2 | IACT |
| polyethylene glycol 1450 | OJ4Z5Z32L4 | IACT |
| tert-butyl alcohol | MD83SFE959 | IACT |
| trolamine | 9O3K93S3TK | IACT |
| water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| trolamine | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | EMULSION / TOPICAL | 6 mg | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / TOPICAL | 85 mg | ||
| denatonium benzoate | DENATONIUM BENZOATE | 4YK5Z54AT2 | GEL / TOPICAL | NA | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM / TOPICAL | 103 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | SUSPENSION / ORAL | 4000 mg | ||
| denatonium benzoate | DENATONIUM BENZOATE | 4YK5Z54AT2 | SWAB / TOPICAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / TOPICAL | 1 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOAP / TOPICAL | 0.08 %w/w | ||
| tert-butyl alcohol | TERT-BUTYL ALCOHOL | MD83SFE959 | GEL / TOPICAL | 0.12 %w/w | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | SOLUTION / ORAL | 6108 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SPRAY / NASAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | OINTMENT, AUGMENTED / TOPICAL | 23 mg | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | TABLET, FILM COATED / ORAL | 0.13 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL, METERED / TRANSDERMAL | 14 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / VAGINAL | 2 %w/w | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | OINTMENT / TOPICAL | 921 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM / VAGINAL | 56 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | POWDER / TOPICAL | 0.02 mg/mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | DROPS / NASAL | NA | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / OPHTHALMIC | 4 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | CAPSULE, EXTENDED RELEASE / ORAL | 91 mg | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL, METERED / TRANSDERMAL | 50 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL / TRANSDERMAL | 6 mg | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | SUPPOSITORY / URETHRAL | 9.75 mg | ||
| denatonium benzoate | DENATONIUM BENZOATE | 4YK5Z54AT2 | SOLUTION / TOPICAL | NA | ||
| polyethylene glycol 1450 | POLYETHYLENE GLYCOL 1450 | OJ4Z5Z32L4 | TABLET / ORAL | 0.6 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | EMULSION / TOPICAL | 0.5 %w/w | ||
| trolamine | TROLAMINE | 9O3K93S3TK | GEL, METERED / TOPICAL | 20 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | AEROSOL, METERED / RECTAL | ADJ PH | ||
| trolamine | TROLAMINE | 9O3K93S3TK | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.02 %w/v | ||
| trolamine | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / TRANSDERMAL | 150 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SOLUTION / NASAL | NA | ||
| carbomer homopolymer type c | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | LOTION / TOPICAL | 300 mg | ||
| trolamine | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 49997a44-d29b-4228-ab6e-c6de0b4133ed | c2ef3aef-4387-41a0-bdd1-d579dfe4199d | 2009-11-20 | Warnings | 49997a44-d29b-4228-ab6e-c6de0b4133ed c2ef3aef-4387-41a0-bdd1-d579dfe4199d |
Adverse event summaries are temporarily unavailable. Other product information remains available.